![Shirish Hirani](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Shirish Hirani
No open positions remaining
Profile
Shirish Hirani worked as Vice President of Drug Development at ARIAD Pharmaceuticals, Inc. from 2005 to 2017.
Prior to that, he held the same position at Transkaryotic Therapies, Inc. from 2002 to 2005 and was Senior Vice President of Product Development at Dyax Corp.
from 1997 to 2002.
He also served as SVP of Program Management & Product Planning at ArQule, Inc. Dr. Hirani received his undergraduate and doctorate degrees from Queen Elizabeth College.
Former positions of Shirish Hirani
| Companies | Position | End |
|---|---|---|
| ARIAD PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/04/2017 |
Transkaryotic Therapies, Inc.
 Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and markets biopharmaceutical products | Corporate Officer/Principal | 01/01/2005 |
| DYAX CORP. | Corporate Officer/Principal | 01/01/2002 |
| ARQULE, INC. | Corporate Officer/Principal | - |
Training of Shirish Hirani
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
61
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
ARIAD Pharmaceuticals, Inc.
 ARIAD Pharmaceuticals, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes small-molecule drugs for the treatment of cancer | Health Technology |
Transkaryotic Therapies, Inc.
Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and markets biopharmaceutical products | Commercial Services |
ArQule, Inc.
 ArQule, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that researches and develops therapeutics to treat cancers & rare diseases | Health Technology |
Dyax Corp.
 Dyax Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of novel biotherapeutics | Health Technology |
Queen Elizabeth College
 Queen Elizabeth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Shirish Hirani
Choose MarketScreener 
